GLP-based medications mimic naturally occurring hormones that help regulate appetite, digestion, and blood sugar. They can help increase feelings of fullness, reduce hunger and cravings, slow stomach emptying, and improve blood-sugar regulation—supporting weight management and overall metabolic health.

GLP-based treatments may be appropriate for certain adults seeking support with weight management, appetite control, or blood-sugar regulation.

FDA approved medications have been reviewed by the FDA for safety, effectiveness, quality, and specific approved uses.

Compounded medications are prepared by authorized pharmacies or compounders to meet individual patient needs. They are not FDA-approved, and the FDA does not review them for safety and effectiveness before they are marketed.

GLP-based medications can support weight loss by reducing appetite, increasing feelings of fullness, and helping regulate food intake. They can also slow stomach emptying and improve blood-sugar regulation, which may help reduce hunger and cravings.

When combined with healthy nutrition, physical activity, and appropriate medical guidance, these effects can help support sustainable weight-management goals.

The most common side effects of GLP-based medications are gastrointestinal, particularly when starting treatment or increasing the dose. These may include:

• Nausea

• Vomiting

• Diarrhea

• Constipation

• Stomach discomfort or abdominal pain

• Bloating

• Decreased appetite

Collaborative, honest, and sGLP-based medications are available in different forms, depending on the specific medication. Many commonly used GLP-based treatments are administered as subcutaneous injections, typically in the abdomen, thigh, or upper arm. Some products are taken orally.

The dosing schedule varies by medication. Many injectable GLP-based treatments are taken once weekly, while some GLP medications are taken daily. Treatment is often started at a lower dose and gradually increased.

Weight-loss results vary from person to person and depend on factors such as the specific medication, dosage, starting weight, diet, activity level, and individual response to treatment.

In clinical studies, some FDA-approved GLP-based medications have been associated with meaningful weight loss over time, particularly when combined with nutrition and lifestyle changes. However, there is no guaranteed amount of weight loss, and individual results will vary.

Yes. GLP-based medications can help support long-term weight management when used as part of an ongoing treatment plan that includes healthy nutrition, physical activity, and appropriate medical supervision.

Research suggests that continuing treatment may help maintain weight loss for many people, while stopping therapy can lead to some weight regain.

GLP-based medications work best as part of a comprehensive approach to weight management. While medication can help reduce appetite and support portion control, healthy nutrition and regular physical activity remain important.

Focus on nutrient-dense foods, adequate protein and hydration, and regular movement that fits your abilities and lifestyle.

Common side effects such as nausea, bloating, constipation, or diarrhea may improve as your body adjusts to treatment. Helpful strategies include:

• Eat smaller meals and eat slowly.

• Stay well hydrated throughout the day.

• Choose lighter, lower-fat foods if nausea occurs.

• Avoid overeating or eating too quickly.

• Follow your prescribed dosing schedule and only increase your dose as directed.

• Contact your healthcare professional if side effects are severe, persistent, or worsening.

Seek medical attention promptly for severe abdominal pain, persistent vomiting, signs of dehydration, or other concerning symptoms.

Some people may experience weight regain after stopping GLP-based medication, particularly if appetite and food intake increase once treatment is discontinued. The amount of weight regained varies from person to person.

Long-term weight management typically involves a combination of healthy nutrition, regular physical activity.

Retatrutide is an investigational medication designed to activate three hormone receptors: GIP, GLP-1, and glucagon. Because it targets three pathways involved in metabolism, it is often referred to as a triple agonist.

Clinical trials are evaluating retatrutide for its potential role in weight management, blood-sugar regulation, and other aspects of metabolic health.

Important: Retatrutide is not currently FDA-approved and remains investigational. It is legally available through clinical trials while its safety and effectiveness continue to be evaluated.

Traditional GLP-1 medications primarily target the GLP-1 receptor, which plays a role in appetite, fullness, and blood-sugar regulation.

Retatrutide is different because it targets three hormone pathways at once: GIP, GLP-1, and glucagon. This is why it is classified as a triple agonist. Researchers are studying whether this multi-pathway approach can provide additional benefits for weight management and metabolic health.

Important: Retatrutide remains an investigational medication and is not currently FDA-approved. It is legally available only through clinical trials.